Using mammogram images and AI to improve breast cancer risk prediction
Advancing breast cancer risk prediction in national cohorts: the role of mammogram-based deep learning
This project uses artificial intelligence on mammograms plus genetic risk information to make more accurate breast cancer risk predictions for women, with a focus on improving results for Black women.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11143084 on NIH RePORTER |
What this research studies
From a patient's point of view, researchers are running AI algorithms on routine mammogram images and combining those image-based risk scores with genetic risk scores to create a fuller picture of breast cancer risk. They are doing this using data from two large U.S. cohorts that include many Black women so the tools work well across groups. The team will compare how well the AI-based models perform versus traditional risk tools and will test whether adding genetic information helps. The goal is to validate these approaches in real-world screening populations rather than only in specialized clinical samples.
Who could benefit from this research
Good fit: The focus is on adult women who have screening mammograms and are represented in large U.S. cohorts—especially Black and non-Hispanic white women included in the Sister Study or the Black Women's Health Study.
Not a fit: Men, people without mammograms or genetic data, and racial/ethnic groups not well represented in the cohorts are unlikely to benefit directly from these results.
Why it matters
Potential benefit: If successful, this work could give women more accurate and equitable personalized risk estimates to guide screening and prevention decisions.
How similar studies have performed: Early studies suggest AI on mammograms can outperform traditional risk models, but combining imaging with genetic risk scores and validating performance in large Black cohorts is largely new.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Tehranifar, Parisa — Columbia University Health Sciences
- Study coordinator: Tehranifar, Parisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.